Evidence map›Paper›PMID 37025382›Full record

ReviewFrontiers in physiology2023

Pathophysiology of Ca

Sahil Zaveri, Ujala Srivastava, Yongxia Sarah Qu, Mohamed Chahine, Mohamed Boutjdir

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Impact of CaInternational journal of molecular sciences · 2026
    Review
  3. C-Terminus of CaCells · 2026
    Article
  4. Article
  5. Article
  6. Nanoscale architecture and dynamics of CaJournal of molecular and cellular cardiology plus · 2025
    Article
  7. RNA Therapeutics in Heart Failure.Journal of cardiovascular translational research · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Ion channel trafficking implications in heart failure.Frontiers in cardiovascular medicine · 2024
    Review
  19. Biophysical properties of NaScientific reports · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sahil ZaveriCardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.
Ujala SrivastavaCardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.
Yongxia Sarah QuCardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.
Mohamed ChahineCERVO Brain Research Center, Institut Universitaire en Santé Mentale de Québec, Québec, QC, Canada.
Mohamed BoutjdirCardiovascular Research Program, VA New York Harbor Healthcare System, New York, NY, United States.
State University of New York · USVA NY Harbor Healthcare System · USInstitut Universitaire en Santé Mentale de Québec · CA

Funding

Rescue of Autoimmune-Associated Long QT Syndrome by Decoy PeptidesR01HL164415 · NHLBI · NARROWS INSTITUTE FOR BIOMEDICAL RES INC · PI BOUTJDIR, MOHAMED, CARDOZO, TIMOTHY J · 2022 to 2025
$2.3M
BLRD VA I01 BX002137NHLBI NIH HHS R01 HL164415
6 · The paper itself

Abstract

Ca

Indexed as

atrial fibrillationcalcium channelheart failureprotein kinase regulationsinoatrial node dysfunction

Identifiers

PMID37025382
PMCPMC10070707
OpenAlexW4328113282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.